Randomized Double-Blinded Phase II Trial of Esomeprazole Versus Esomeprazole + Two Doses of Aspirin in Barretts Esophagus Patients
Title: Randomized, Double-Blinded Phase II Trial of Esomeprazole Versus Esomeprazole + Two Doses of Aspirin in Barrett's Esophagus Patients
Description: Sponsored by the National Cancer Institute.
Purpose of the study is to find out what the effects of esomeprazole and aspirin (when given at the same time) have on patients with Barrett's esophagus with no dysplasia in the risk for cancer of the esophagus.
IRB Number: CPN 1206-CC117
Clinical Area: Upper GI Disorders
Principal Name: Gary W. Falk, MD, MS
Contact Name: Mary Oldenburgh, RN
Fax: (216) 445-6032
Phone: (216) 444-8562